Table 3 Comparison of SSc subset and autoantibody prevalence between two EUSTAR centres within a single city

Centre	N	% dcSSc	% lcSSc	% Scl70	% ACA
Berlin, Charité, Dermatology	39	17.9**	82.1**	20.5	41.0
Berlin, Charité, Rheumatology	170	51.1**	48.2**	25.3	40.0
Lublin, University Hospital, Dermatology	40	2.5**	97.5**	45.0**	27.5*
Lublin, University Hospital, Rheumatology	36	58.3**	41.7**	41.7**	11.1*
Madrid, Hospital Ramon Cajal, Rheumatology	20	60.0	40.0	45.0	25.0
Madrid, Hospital 12 de Octubre, Rheumatology	73	46.6	53.4	38.4	30.1
Milan, University Hospital, Immunology	132	30.3*	69.7*	40.9	36.4
Milan, Gaetano Pini Hospital, Rheumatology	50	56.0*	44.0*	56.0	42.0
Paris, Cochin University Hospital, Rheumatology	73	56.2**	43.8**	42.5	12.3**
Paris, Saint Louis, Internal Medicine	47	80.9**	19.1**	53.2	2.1**
Prague, Charles University, Dermatology	16	43.8**	56.2**	68.8	6.3
Prague, Charles University, Rheumatology	24	8.3**	91.7**	70.8	8.3

The asterisks indicate that the variances of the populations are not equal between centres by Levene’s testing. *p<0.05; **p<0.001. ACA, anticentromere autoantibody; dcSSc, diffuse cutaneous systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis; SSc, systemic sclerosis.